Korean J Helicobacter Up Gastrointest Res.  2017 Mar;17(1):11-15. 10.7704/kjhugr.2017.17.1.11.

Management of Helicobacter pylori Infection in Europe: Focusing on the Maastricht V/Florence Consensus

• Shin WG

• KMID: 2391604
• DOI: http://doi.org/10.7704/kjhugr.2017.17.1.11

Abstract

In the fifth edition of the Maastricht Consensus Conference, quadruple regimens for primary treatment of Helicobacter pylori infection such as concomitant or bismuth quadruple therapy have been recommended in areas of high clarithromycin resistance. In addition, the Maastricht Consensus V highlighted the importance of population- and individual-based susceptibility tests to detect possible antibiotic resistance in patients with a history of intake of any of the key antibiotics, even if the population has a low resistance rate.

Keyword

Helicobacter pylori; Consensus

MeSH Terms

Anti-Bacterial Agents
Bismuth
Clarithromycin
Consensus*
Drug Resistance, Microbial
Europe*
Helicobacter pylori*
Helicobacter*
Humans
Anti-Bacterial Agents
Bismuth
Clarithromycin